Noveris Health Sciences is trading 27.78% down now at $0.33 after continued profit-taking following its sharp late-July run-up.

  • The decline follows a 52.13% drop on August 6 and a 12.96% decline on August 5, indicating sustained selling in a highly volatile, thinly traded stock.
  • Management said on August 6 that it was unaware of any material operational change explaining the recent market activity; no fresh company-specific catalyst has been identified.